The potential of KRAS inhibitors for non-small-cell lung cancer
Prof Reinhard Büttner - University Hospital Cologne, Cologne, Germany
22 Apr 2020
COVID-19: The management of coronavirus patients with cancer, examples from Ital...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
31 Mar 2020
Management of mutation-negative NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
6 Mar 2020
Systematic therapy of driver mutated NSCLC
Dr Vijay Patil - Tata Medical Center, Kolkata, India
6 Mar 2020
Loco-regionally advanced NSCLC: Radiation oncologist's perspective
Prof Simon Pavamani - Christian Medical College, Vellore, India
6 Mar 2020
Node-positive NSCLC: A surgeons point of view
Dr Robin Thambudorai- Tata Medical Center, Kolkata, India
6 Mar 2020
Working up metastatic NSCLC
Dr Depak Dabkara - Tata Medical Center, Kolkata, India
6 Mar 2020
Treatment of early stage adenocarcinoma
Dr C S Pramesh - Tata Memorial Hospital, Mumbai, India
20 Feb 2020
Choosing wisely: Lung adenocarcinoma
Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chan...
18 Feb 2020
Diagnosis and staging of lung adenocarcinoma
Dr Navneet Singh - Government Medical College and Hospital, Chandigarh, India
13 Feb 2020
Treatment of late stage adenocarcinoma
Dr Nitesh Rohatgi- Max Healthcare, New Delhi, India
13 Feb 2020
Cancer registry in Tanzania and the lung cancer control program
Dr Nestory Masalu - Bugando Medical Centre, Mwanza City, Tanzania
7 Feb 2020
